3 news items
Cerus Corporation Announces First Quarter 2024 Financial Results
CERS
2 May 24
, and we are committed to providing the full INTERCEPT portfolio for all transfused blood components to our customers around the globe
Cerus Corporation Announces FDA Approval Of Extended Shelf Life For INTERCEPT Platelet Processing Sets, Doubling Previous Shelf Life
CERS
26 Mar 24
change last year. All INTERCEPT Platelet Processing Sets in both customer and Cerus inventories are now eligible for this six-month extension. This shelf
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
CERS
26 Mar 24
that took effect following a set component change last year. All INTERCEPT Platelet Processing Sets in both customer and Cerus inventories are now eligible
- Prev
- 1
- Next